Authors: JURINCICWINKLER CD HORLBECK R VONDERKAMMER H SCHEIT KH KLIPPEL KF

Citation: Cd. Jurincicwinkler et al., ADJUVANT IMMUNOTHERAPY WITH KEYHOLE LIMPE T HEMOCYANIN (KLH) IN RENAL-CELL CARCINOMA FOR CATEGORY PT 2 N-4, NO-N+, MO( AND PT 3), Wiener Klinische Wochenschrift, 106(14), 1994, pp. 455-458

Authors: JURINCICWINKLER C VONDERKAMMER H HORLBECK R KLIPPEL KF PIXBERG HU SCHEIT KH

Citation: C. Jurincicwinkler et al., CLINICAL-EVALUATION OF A NEW PROSTATE-SPECIFIC ANTIGEN SANDWICH ELISAWHICH EMPLOYS 4 MONOCLONAL-ANTIBODIES DIRECTED AT DIFFERENT EPITOPES OF PROSTATE-SPECIFIC ANTIGEN, European urology, 24(4), 1993, pp. 487-491

Authors: VONDERKAMMER H JURINCICWINKLER C HORLBECK R KLIPPEL KF PIXBERG HU SCHEIT KH

Citation: H. Vonderkammer et al., THE POTENTIAL USE OF PROSTATIC SECRETORY PROTEIN OF 94 AMINO-ACID-RESIDUES (PSP(94)) AS A SERUM MARKER FOR PROSTATIC TUMOR, Urological research, 21(3), 1993, pp. 227-233

Authors: JURINCICWINKLER C HORLBECK R KLIPPEL KF

Citation: C. Jurincicwinkler et al., RECOMBINANT INTERFERON-ALPHA-2A AND INTER LEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Wiener Klinische Wochenschrift, 105(10), 1993, pp. 271-276